The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Jyotika D. Prasad; Annabelle Mahar; Jane Bleasel; Samantha J. Ellis; Daniel C. Chambers; Fiona Lake; Peter M.A. Hopkins; Tamera J. Corte; Heather Allan; Ian N. Glaspole

doi:10.1111/resp.13163

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Jyotika D. Prasad, Annabelle Mahar, Jane Bleasel, Samantha J. Ellis, Daniel C. Chambers, Fiona Lake, Peter M.A. Hopkins, Tamera J. Corte, Heather Allan, Ian N. Glaspole

Central Clinical School

Research output: Contribution to journal › Article › Other › peer-review

35 Citations (Scopus)

Abstract

Interstitial lung diseases (ILD) are a diverse group of pulmonary diseases for which accurate diagnosis is critical for optimal treatment outcomes. Diagnosis of ILD can be challenging and a multidisciplinary approach is recommended in international guidelines. The purpose of this position paper is to review the evidence for the use of the multidisciplinary meeting (MDM) in ILD and suggest an approach to its governance and constitution, in an attempt to provide a standard methodology that could be applied across Australia and New Zealand. This position paper is endorsed by the Thoracic Society of Australia and New Zealand (TSANZ) and the Lung Foundation Australia (LFA).

Original language	English
Pages (from-to)	1459-1472
Number of pages	14
Journal	Respirology
Volume	22
Issue number	7
DOIs	https://doi.org/10.1111/resp.13163
Publication status	Published - 1 Oct 2017

Keywords

clinical respiratory medicine
interstitial lung disease
multidisciplinary meeting
pulmonary fibrosis
rare lung diseases

Access to Document

10.1111/resp.13163

Cite this

Prasad, J. D., Mahar, A., Bleasel, J., Ellis, S. J., Chambers, D. C., Lake, F., Hopkins, P. M. A., Corte, T. J., Allan, H., & Glaspole, I. N. (2017). The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology, 22(7), 1459-1472. https://doi.org/10.1111/resp.13163

@article{cef9725b9f764ec5b57e4b7317e32e14,

title = "The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia",

abstract = "Interstitial lung diseases (ILD) are a diverse group of pulmonary diseases for which accurate diagnosis is critical for optimal treatment outcomes. Diagnosis of ILD can be challenging and a multidisciplinary approach is recommended in international guidelines. The purpose of this position paper is to review the evidence for the use of the multidisciplinary meeting (MDM) in ILD and suggest an approach to its governance and constitution, in an attempt to provide a standard methodology that could be applied across Australia and New Zealand. This position paper is endorsed by the Thoracic Society of Australia and New Zealand (TSANZ) and the Lung Foundation Australia (LFA).",

keywords = "clinical respiratory medicine, interstitial lung disease, multidisciplinary meeting, pulmonary fibrosis, rare lung diseases",

author = "Prasad, {Jyotika D.} and Annabelle Mahar and Jane Bleasel and Ellis, {Samantha J.} and Chambers, {Daniel C.} and Fiona Lake and Hopkins, {Peter M.A.} and Corte, {Tamera J.} and Heather Allan and Glaspole, {Ian N.}",

year = "2017",

month = oct,

day = "1",

doi = "10.1111/resp.13163",

language = "English",

volume = "22",

pages = "1459--1472",

journal = "Respirology",

issn = "1323-7799",

publisher = "Wiley-Blackwell",

number = "7",

}

Prasad, JD, Mahar, A, Bleasel, J, Ellis, SJ, Chambers, DC, Lake, F, Hopkins, PMA, Corte, TJ, Allan, H & Glaspole, IN 2017, 'The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia', Respirology, vol. 22, no. 7, pp. 1459-1472. https://doi.org/10.1111/resp.13163

TY - JOUR

T1 - The interstitial lung disease multidisciplinary meeting

T2 - A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

AU - Prasad, Jyotika D.

AU - Mahar, Annabelle

AU - Bleasel, Jane

AU - Ellis, Samantha J.

AU - Chambers, Daniel C.

AU - Lake, Fiona

AU - Hopkins, Peter M.A.

AU - Corte, Tamera J.

AU - Allan, Heather

AU - Glaspole, Ian N.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Interstitial lung diseases (ILD) are a diverse group of pulmonary diseases for which accurate diagnosis is critical for optimal treatment outcomes. Diagnosis of ILD can be challenging and a multidisciplinary approach is recommended in international guidelines. The purpose of this position paper is to review the evidence for the use of the multidisciplinary meeting (MDM) in ILD and suggest an approach to its governance and constitution, in an attempt to provide a standard methodology that could be applied across Australia and New Zealand. This position paper is endorsed by the Thoracic Society of Australia and New Zealand (TSANZ) and the Lung Foundation Australia (LFA).

AB - Interstitial lung diseases (ILD) are a diverse group of pulmonary diseases for which accurate diagnosis is critical for optimal treatment outcomes. Diagnosis of ILD can be challenging and a multidisciplinary approach is recommended in international guidelines. The purpose of this position paper is to review the evidence for the use of the multidisciplinary meeting (MDM) in ILD and suggest an approach to its governance and constitution, in an attempt to provide a standard methodology that could be applied across Australia and New Zealand. This position paper is endorsed by the Thoracic Society of Australia and New Zealand (TSANZ) and the Lung Foundation Australia (LFA).

KW - clinical respiratory medicine

KW - interstitial lung disease

KW - multidisciplinary meeting

KW - pulmonary fibrosis

KW - rare lung diseases

UR - http://www.scopus.com/inward/record.url?scp=85029222192&partnerID=8YFLogxK

U2 - 10.1111/resp.13163

DO - 10.1111/resp.13163

M3 - Article

AN - SCOPUS:85029222192

VL - 22

SP - 1459

EP - 1472

JO - Respirology

JF - Respirology

SN - 1323-7799

IS - 7

ER -

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Abstract

Keywords

Access to Document

Other files and links

Cite this